Healthcare -
Biotechnology - NASDAQ - US
$ 5.16
-2.27 %
$ 46 M
Market Cap
-19.85
P/E
ICCC - LONG-TERM DEBT
Long-term Debt ICCC - ImmuCell Corporation
14.6 M
LAST VALUE
25.01%
2 YEAR CAGR
11.66%
5 YEAR CAGR
32.20%
10 YEAR CAGR